A closely watched cardiovascular drug from Novartis failed in a pivotal study, the company said Friday, a major blow to the ...

In the months before killing her children, Lindsay Clancy repeatedly sought help for her deteriorating mental health.

After the failure of an experimental drug for Angelman syndrome, experts cautioned that there is still reason to think ...

An organ transplant first, new details on ADA conference controversy, and more health news from Morning Rounds ...

On Feb. 24, 2025, the Food and Drug Administration did something it arguably should have done long ago: It removed the ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Is CDC now applying different standards to state data depending on who governs the state or what political party won an ...

Two recipients of gene-edited pig kidneys have successfully received human organs, a milestone in the wider effort to advance ...

Experts agreed that the biggest threat to progress on overdose deaths is the looming Medicaid cuts. Researchers at Penn’s ...

AI products from Cadence and Limbic are among four devices recently accepted into the FDA’s TEMPO pilot that will allow ...

At a "practice of last resort," pediatricians prioritize allaying parents' vaccine concerns without hardline dismissals.

Today, a look at how some generative AI medical devices are getting on the market quickly. Plus: OpenEvidence’s new AI models ...